Clinical Trial Update: Neurocognition After Perturbed Sleep [NA]

View source ↗

Summary

This is a completed clinical trial assessing neurocognition after perturbed sleep in individuals with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Schizophrenia | NA | Status: COMPLETED